Clinical differential diagnosis of parkinsonism

Future Neurology

Volumn 3, Issue 3, 2008, Pages 287-298

  Colosimo, Carlo ^a   Tiple, Dorina ^a   Berardelli, Alfredo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Differential diagnosis; Multiple system atrophy; Parkinson's disease; Parkinsonism; Progressive supranuclear palsy

Indexed keywords

ANTIEMETIC AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CINNARIZINE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUNARIZINE; LEVODOPA; NEUROLEPTIC AGENT;

AUTONOMIC DYSFUNCTION; BALANCE DISORDER; BEHAVIOR DISORDER; BRADYKINESIA; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICOBASAL DEGENERATION; DAYTIME SOMNOLENCE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSKINESIA; DYSTONIA; EYE DISEASE; GAIT DISORDER; HUMAN; HYPOSMIA; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NONHUMAN; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PREDICTION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SENSITIVITY AND SPECIFICITY; SENSORY DYSFUNCTION; SHY DRAGER SYNDROME; SLEEP DISORDER; TREATMENT PLANNING; TREMOR; UROGENITAL TRACT DISEASE; VASCULAR DISEASE; WILSON DISEASE; XEROSTOMIA;

EID: 44149084020     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/14796708.3.3.287     Document Type: Review

References (92)

1. Lirvan I, Bhatia KP, Burn DJ et al.: Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disord. 18, 467-486 (2003).
2. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ: The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 125, 861-870 (2002).
3. Katzenschlager R, Cardozo A, Avila Cobo MA, Tolosa E, Lees AJ: Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Mov. Disord. 18, 1123-1131 (2003).
4. Hoehn MM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 17, 427-442 (1967).
5. Poewe WH, Wenning GK: The natural history of PD. Ann. Neurol. 44, S1-S9 (1998).
6. Hughes AJ, Daniel SE, Blankson S, Lees AJ: A clinicopathologic study of 100 cases of Parkinson's disease. Arch. Neurol. 50, 140-148 (1993).
7. Deuschl G, Bain P, Brin M: Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov. Disord. 13, 2-23 (1998).
8. Hunker CJ, Abbs JH: Uniform freequency of 21 parkinsonian resting tremor in the lips, jaw, tongue, and index finger. Mov. Disord. 5, 71-77 (1990).
9. Verghese J, Lipton RB, Dickson DW, Crystal HJ: A clinicopathological study of rest tremors in the elderly. J. Am. Geriatr. Soc. 52, 1781-1783 (2004).
10. Meara J, Bhowmick BK, Hobson P: Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 28, 99-102 (1999).
11. Quinn NP: How to diagnose multiple system atrophy. Mov. Disord. 20, S5-S10 (2005).
12. Wenning GK, Shlomo IB, Magalhaes M et. al.: Clinical features and natural history of multiple system atrophy. Brain 117, 835-845 (1994).
13. Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ: Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch. Neurol. 52, 294-298 (1995).
14. Williams DR, De Silva R, Paviour DC et al.: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 128, 1247-1258 (2005).
15. Kompoliti K, Goetz CG, Boeve BF et al.: Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch. Neurol. 55, 957-961 (1998).
16. Bower JH, Maraganore DM, McDonnell SK, Rocca WA: Incidence and distribution of parkinsonism in Olmsted County; Minnesota, 1976-1990. Neurology 52, 1214-1220 (1999).
17. Critchley M: Arteriosclerotic parkinsonism. Brain 52, 23-83 (1929).
18. Bower JH, Dickson DW, Taylor L et al.: Clinical correlates of the pathology underlying parkinsonism: a population perspective. Mov. Disord. 17, 910-916 (2002).
19. Miwa H, Hatori K, Kondon T, Imah H, Mizuno Y: Thalamic tremor: case reports and implications of the tremor-generating mechanisms. Neurology 46, 75-79 (1996).
20. Machado A, Chien HF, Deguti MM et al.: Neurological manifestations in Wilson's disease. Mov. Disord. 21, 2192-2196 (2006).
21. Matsuo H, Takashima H, Kishikawa M et al.: Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 54, 397-400 (1991).
22. Litvari I, Campbell G, Mangone CA et al.: Which clinical features differentiate progressive supranuclear palsy from related disorders? A clinicopathological study. Brain 120, 65-74 (1997).
23. Stover NP, Watts RL: Corticobasal degeneration. Semin. Neurol. 21, 49-58 (2001).
24. Chou KL, Friedman JH: Drug-induced parkinsonism in the elderly. Future Neurol. 2, 307-316 (2007).
25. Demirkiran M, Bozdemir H, Sarica Y: Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol. Scand. 104, 63-67 (2001).
26. Schabitz WR, Glatz K, Schuhan C et al.: Severe forward flexion of the trunk in Parkinsods disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov. Disord. 18, 408-414 (2003).
27. Gouider-Khouja N, Vidaihet M, Bonner AM et al.: Pure striatonigral degeneration and Parkinson's disease: a comparative clinical study. Mov. Disord. 10, 288-294 (1995).
28. Zodikoff C, Lang AE: Apraxia in movement disorders. Brain 128, 1480-1497 (2005).
29. Doody RS, Jankovic J: The alien hand and related sign. J. Neurol. Neurosurg. Psychiatry 55, 806-810(1999).
30. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM: Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J. Neurol. Neurosurg. Pychiatry. 58, 167-173 (1995).
31. Mark MH, Sage JI, Walters AS et al.: Binswanger disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov. Disord. 10, 450-454 (1995).
32. Tuite PJ, Krawczewski K: Parkinsonism: a review-of-systems approach to diagnosis. Semin. Neurol. 27, 113-122 (2007).
33. Zijlmans JCM, Poels PJE, Duysens J et al.: Quantitative gait analysis in patients with vascular parkinsonism. Mov. Disord. 11, 501-508 (1996).
34. Colosimo, C: Pisa syndrome in a patient with multiple system atrophy. Mov. Disord. 13, 607-609 (1998).
35. Ebeisbach G, Sojet M, Valldeoriola F et al.: Comparative analysis of gait in Parkinson's disease, cerebellar ataxia and subcortical arteriosclerotic encephalopathy. Brain 122, 1349-1355 (1999).
36. Romano S, Colosimo C: Procerus sign in progressive supranuclear palsy. Neurology 57, 1928 (2001).
37. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G: Wilson's disease: clinical Presentation, treatment, and survival. Ann. Intern. Med. 115, 720-726 (1991).
38. Garbutt S, Riley DE, Kumar AN et al.: Abnormalities of optokinetic nystagmus in progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 75, 1386-1394 (2004).
39. Rivaud-Pechoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot-Deseilliqny C: Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology 54, 1029-1032 (2000).
40. Mendez MF: Corticobasal ganglionic degeneration with Balint's syndrome. J. Neuropsych. Clin. Neurosci. 12, 273-275 (2000).
41. Hoogenraad T. Clinical manifestation. In: Wilson's Disease. Hoogenraad T (Ed.). WB Saunders, London, UK 71-108 (1996).
42. Lee MS, Kim YD, Lyoo CH: Oculogyric crisis as an initial manifestation of Wilson's disease. Neurology 52, 1714-1715 (1999).
43. Katzenschlager R, Lees A: Olfaction and Parkinson's syndromes: its role in differential diagnosis. Curr. Opin. Neurol. 17, 417-423 (2004).
44. Markopoulou K, Larsen KW, Wszolek EK et al.: Olfactory dysfunction in familial parkinsonism. Neurology 49, 1262-1267 (1997).
45. Hawkes CH, Shephard BC: Olfactory evoked responses and identification tests in neurological disease. Ann. NY Acad. Sci. 855, 608-15 (1998).
46. Doty RL, Deems DA, Stellar S: Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage or disease duration. Neurology 38, 1237-1244 (1988).
47. Tissingh G, Berendse HW, Bergmans P et al.: Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov. Disord. 16, 41-46 (2001).
48. Sobel N, Prabhakaran V, Hartley CA et al.: Odorant-induced and sniff-induced activation in the cerebellum of the human. J. Neurosci. 18, 8990-9001 (1998).
49. Wenning GK, Shephard B, Magalhaes M et al.: Olfactory function in multiple system atrophy. Neurodegeneration 2, 169-171 (1993).
50. Abele M, Riet A, Hummel T et al.: Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J. Neurol. 250, 1453-1455 (2003).
51. Wenning GK, Shephard B, Hawkes C et al.: Olfactory function in progressive supranuclear palsy and corticobasal degeneration. J. Neurol. Neurosurg. Psychiatry 57, 251-252 (1995).
52. Doty RL, Golbe LI, McKeown DA et al.: Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43, 962-965 (1993).
53. Winikates J, Jankovic J: Clinical correlates of vascular parkinsonism. Arch. Neurol. 56, 98-102 (1999).
54. Hensiek AE, Bhatia K, Hawkes CH: Olfactory function in drug-induced parkinsonism. J. Neurol. 247, P303 (2000).
55. Mueller A, Reuner U, Landis B et al.: Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction. Mov. Disord. 21, 1311-1316 (2006).
56. Chaudhuri KR: Nocturnal symptoms complex in PD and its management. Neurology 61, S17-S23 (2003).
57. Cagnon JF, Bedard MA, Fantini ML et al.: REM sleep behaviour disorder and REM sleep without atonia in Parkinson's disease. Neurology 59, 585-589 (2002).
58. Abbott RD, Ross GW, White LR et al.: Excessive daytime sleepiness and the future risk of Parkinson's disease. Mov. Disord. 20, S101 (2005).
59. Ghorayeb I, Bioulac B, Tison F: Sleep disorders in multiple system atrophy. J. Neural Transm. 112, 1669-1675 (2005).
60. Aldrich MS, Foster NL, White RF et al.: Sleep abnormalities in progressive supranuclear palsy. Ann. Neurol. 25, 577-581 (1989).
61. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE: Association of REM sleep behaviour disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov. Disord. 16, 622-630 (2001).
62. Portala K, Westermark K, Ekselius L, Broman JE: Sleep in patients with treated Wilson's disease. A questionnaire study. Nord. J. Pychiatry 56, 291-297 (2002).
63. Goldstein DS: Dysautonomia in Parkinson's disease: neurocardiological abnormalities. Lancet Neurol. 2, 669-676 (2003).
64. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the Amerlcan Academy of Neurology. Neurology 46, 1470 (1996).
65. Gilman S, Low PA, Quinn N et al.: Consensus statement on the diagnosis of multiple system atrophy. J. Neurol. Sci. 163, 94-98 (1999).
66. Holmberg B, Kallio M, Johnels B, Elam M: Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of parkinsonian syndromes. Mov. Disord. 16, 217-225 (2001).
67. Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 3, 93-103 (2004).
68. Sibon I, Tison F: Vascular parkinsonism. Curr. Opin Neurol. 17, 49-54 (2004).
69. Sakakibara R, Shinocoh H, Uchiyama T et al.: Questionnaire-based assessment of pelvic organ. dysfunction in Parkinson's disease. Auton. Neurosci. 92, 76-85 (2001).
70. Brown RG, Jahanshahi M, Quinn N, Marsden CD: Sexual function in patients with Parkinson's disease and their partners. J. Neurol Neurosurg. Psychiatry 12, 480-486 (1990).
71. Kirchhof K, Apostolidis AN, Mathias CJ et al.: Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study. Int. J. Impot. Res. 15, 293-298 (2003).
72. Oertel WH, Wachter T, Quinn NP et al.: Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov. Disord. 18, 430-432 (2003).
73. Colosimo C, Geser F, Benarroch EE, Wenning GK. Multiple system atrophy. In: Neurobiology of Disease. Gilman S (Ed.). Academic Press, CA, USA 83-93 (2007).
74. Quinn N, Koller WC, Lang AE, Marsden CD: Painful Parkinson disease. Lancet 1, 1366-1369 (1996).
75. Chaudhuri KR, Healy DG, Schapira A: Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 5, 235-245 (2006).
76. Ford B, Louise P, Greene P et al.: Oral and genital pain syndromes in Parkinson's disease. Mov. Disord. 11, 421-426 (1996).
77. Stover NP, Watts RL: Corticobasal degeneration. Semin. Neurol. 21, 49-58 (2001).
78. Belfor N, Amici S, Boxer AL et al.: Clinical and neuropsychological features of corticobasal degeneration. Mech. Ageing Dev. 127, 203-207 (2006).
79. Pharr V, Uttl B, Stark M, Lirvan I, Fantie B, Grafman I: Comparison of apraxia in corticobasal degeneration and progressive suprnuclear palsy. Neurology 56, 957-963 (2001).
80. Rektor I, Rektorova I, Kubova D: Vascular parkinsonism - an update. J. Neurol. Sci. 248, 185-191 (2006).
81. Shiba M, Bower JH, Maraganore DM et al.: Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov. Disord. 15, 6659-677 (2000).
82. Burn DJ: Beyond the iron masic towards better recognition and treatment of depression associated with Parkinson's disease. Mov. Disord. 17, 445-454 (2002).
83. O'Brien JT, Erkinjuntti T, Reisberg B et al.: Vascular cognitive impairment. Lancet Neurol. 2, 89-98 (2003).
84. Aarsland D, Litvan I, Larsen JP: Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J. Neuropsychiatry Clin Neurosci. 13, 42-49 (2001).
85. Burn DJ, Lees AJ: Progressive supranuclear palsy: where are we now? Lancet Neurol. 1, 359-369 (2001).
86. Lange KW, Tucha O, Alders GL et al.: Differentiation of parkinsonian syndromes according to dfferences in executive functions. J. Neural Transm. 110, 983-995 (2003).
87. McKeith IG, Galasko D, Kosava K et al.: Consensus guidefines for the clinical and pathologic diagnosis of dementia with Lewy bodies: report of the consortium on DLB international workshop. Neurology 47, 1113-1124 (1996).
88. Lambon RMA, Powell J, Howard D, Whitworth AB, Garrard P, Hodges JR: Semantic memory is impaired in both dementia with Lewy bodies and dementia of Alzheimer ripe: a comparative neuropsychological study and literature review. J. Neurol. Neurosurg. Psychiatry 70, 149-156 (2001).
89. Granalingham KK, Byrne EJ, Thornton A: Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 347, 696-697 (1996).
90. Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y: Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov. Disord. 19, 60-67 (2004).
91. Ballard C, Holmes C, McKeith I et al.: Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer disease. Am. J. Psychiatry 156, 1039-1045 (1999).
92. Graham NL, Bak T, Patterson K et al.: Language function and dysfunction in corticobasal degeneration. Neurology 61, 493-499 (2003).